120.88
0.23%
-0.28
Dopo l'orario di chiusura:
122.69
1.81
+1.50%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché BNTX Giù?
Forum
Previsione
Storia dei dividendi
Biontech Se Adr Borsa (BNTX) Ultime notizie
BioNTech's SWOT analysis: oncology pipeline, cash boost stock outlook - Investing.com
Why This Beaten-Down Stock Is a Buy in 2025 and Beyond - The Motley Fool
Stocks To Watch: BioNTech ADR Sees Relative Strength Rating Rise To 84 - Investor's Business Daily
Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know - MSN
Years-Old List of Alleged Pfizer COVID-19 Vaccine 'Side Effects' Is Misleading - Snopes.com
Why BioNTech (BNTX) Shares Are Volatile TodayBioNTech (NASDAQ:BNTX) - Benzinga
BioNTech SE ADR falls Wednesday, underperforms market - MarketWatch
BioNTech SE ADR rises Tuesday, outperforms market - MarketWatch
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike - Investor's Business Daily
BioNTech SE ADR rises Monday, outperforms market - MarketWatch
BNTX: 3 Genomic Stocks Unlocking the Secrets of DNA - StockNews.com
BioNTech SE ADR rises Friday, still underperforms market - MarketWatch
BioNTech SE ADR rises Thursday, outperforms market - MarketWatch
Russia develops mRNA cancer vaccine for citizens, skepticism lingers - Mugglehead
BioNTech SE ADR falls Monday, underperforms market - MarketWatch
BioNTech SE ADR rises Friday, outperforms market - MarketWatch
BioNTech SE ADR falls Thursday, underperforms market - MarketWatch
BioNTech SE ADR rises Tuesday, still underperforms market - MarketWatch
BioNTech SE ADR rises Monday, still underperforms market - MarketWatch
Stocks Generating Improved Relative Strength: BioNTech ADR - Investor's Business Daily
BioNTech's SWOT analysis: mRNA pioneer's stock faces oncology pipeline test - Investing.com
BioNTech SE ADR falls Friday, underperforms market - MarketWatch
BioNTech SE ADR rises Wednesday, outperforms market - MarketWatch
BioNTech SE ADR falls Tuesday, underperforms market - MarketWatch
BioNTech's SWOT analysis: mRNA pioneer's stock balances COVID legacy, oncology future - Investing.com
Stocks Showing Improving Market Leadership: BioNTech ADR Earns 81 RS Rating - Investor's Business Daily
BioNTech ADR Earns Relative Strength Rating Upgrade - Investor's Business Daily
BioNTech's SWOT analysis: oncology pipeline fuels stock's potential amid market volatility - Investing.com
BioNTech Stock Got A IBD RS Rating Lift - MSN
BioNTech ADR Shows Improved Relative Strength; Still Shy Of Benchmark - Investor's Business Daily
Analysts Turn Bullish on BioNTech Stock Amid Volatility - Schaeffers Research
10 Biggest Biotechnology Companies - Investopedia
The Best Biotech Stocks to Buy - Morningstar
BioNTech SE ADR (BNTX): An Important Analyst Insights - Stocks Register
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):